TD Cowen Downgrades Stoke Therapeutics (STOK) to Market Perform, 'Minimal pipeline progress adds to uncertain outlook'
Tweet Send to a Friend
(Updated - July 25, 2023 2:05 PM EDT)
TD Cowen analyst Yaron Werber downgraded Stoke Therapeutics (NASDAQ: STOK) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TD Cowen analyst Yaron Werber downgraded Stoke Therapeutics (NASDAQ: STOK) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
